EurekaMag.com logo
+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The effect of the triplicate benzodiazepine prescription regulation on sedative hypnotic overdoses



The effect of the triplicate benzodiazepine prescription regulation on sedative hypnotic overdoses



Veterinary & Human Toxicology 32(4): 355




(PDF emailed within 1 workday: $29.90)

Accession: 033785946

Download citation: RISBibTeXText



Related references

Has the New York State triplicate benzodiazepine prescription regulation influenced sedative-hypnotic overdoses?. New York State Journal of Medicine 91(10): 436-439, 1991

Effect of triplicate prescription policy on benzodiazepine administration in nursing home residents. Pharmacotherapy 21(10): 1159-1166, October, 2001

Sleeping too soundly: the effects of sedative/hypnotic drug overdoses. Jems 28(9): 94-117, Quiz 118-9, 2003

Anti-aggregation effect on platelets of Indiplon a hypnotic sedative non-benzodiazepine drug. Biomedicine & PharmacoTherapy 111: 378-385, 2018

Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations. JAMA 266(17): 2392-2397, 1991

Consequences of the 1989 new york state usa triplicate benzodiazepine bzdp prescription regulations. Clinical Pharmacology & Therapeutics 49(2): 149, 1991

Potential impact of OBRA on benzodiazepine and sedative/hypnotic use. Journal of the American Geriatrics Society 41(10 SUPPL ): SA68, 1993

A Comparative EEG Study of Some Benzodiazepine (BZD) and Non-BZD Sedative or Hypnotic Drugs. Pharmacopsychiatry 18(01): 17-19, 1985

Mass balance and pharmacokinetics of zaleplon, a non-benzodiazepine sedative/hypnotic, in man. Pharmaceutical Research (New York) 13(9 SUPPL ): S487, 1996

Electroencephalographic effects of CL284,846, a new non-benzodiazepine sedative-hypnotic, in rabbits. Japanese Journal of Pharmacology 71(SUPPL 1): 181P, 1996

Benzodiazepine and sedative-hypnotic use among older seriously Ill veterans: choosing wisely?. Clinical Therapeutics 36(11): 1547-1554, 2016

Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats. Journal of Pharmacological Sciences 94(3): 246-251, 2004

Detection of sedative hypnotic hop constituents 5. degradation of humulones and lupulones to 2 methyl 3 buten 2 ol a hop constituent possessing sedative hypnotic activity. Archiv der Pharmazie (Weinheim) 316(2): 132-137, 1983

Sedative hypnotic principles in hops. Part 5. Degradation of humulones and lupulones to 2-methyl-3-buten-2-ol, a hop constituent possessing sedative hypnotic activity. Archiv fur Pharmazie 316(2): 132-137, 1983

Detection of sedative-hypnotic active ingredients in hops. 5. Degradation of bitter acids to 2-methyl-3-buten-2-ol, a hop constituent with sedative-hypnotic activity. Archiv der Pharmazie 316(2): 132-137, 1983